ArticleScientific reports2025
The associations between the FAGR and all-cause and cardiovascular mortality in patients with STEMI.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prognostic Value of Albumin/Globulin Ratio for Mortality in Stage 2 Cardiovascular-Kidney-Metabolic Syndrome: A Nationwide Cohort Analysis (1999-2018).High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2026Article
- Admission fibrinogen-to-albumin ratio and mortality in older adults hospitalized with pneumonia: a retrospective cohort study.BMC infectious diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Although the fibrinogen-to-albumin-to-globulin ratio (FAGR) has been proven to be related to coronary artery disease (CAD), the association between the FAGR and acute ST-segment elevation myocardial infarction (STEMI) has not been adequately investigated. This study aimed to evaluate the prognostic potential of the FAGR for STEMI. A total of 1042 patients with STEMI after emergency PCI admitted to the First Affiliated Hospital of Kunming Medical University from June 2018 to January 2023 were enrolled in the study. Patients were divided into a low FAGR group and a high FAGR group according to the median FAGR (2.44). We used Kaplan-Meier plots, restricted cubic spline regression, Cox survival analyses and time-dependent ROC analyses to explore the predictive value of the FAGR for all-cause and cardiovascular mortality. Kaplan‒Meier analysis revealed that the cumulative incidence rates of all-cause and cardiovascular mortality in patients with STEMI were greater in the high FAGR group. Multivariate Cox proportional hazard analysis revealed that the FAGR was an independent predictor of both all-cause and cardiovascular death. In terms of the prediction of all-cause mortality, the FAGR had an area under the ROC curve of 0.720, which was better than that for fibrinogen (AUC = 0.687). In terms of the prediction of cardiovascular mortality, the area under the ROC curve for the FAGR was 0.726, which was also better than that for Fib (AUC = 0.698). The present results suggest that the FAGR may serve as a potential prognostic indicator in patients with STEMI after emergency PCI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.